Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 3/20 | 0.38 |
| ▸ | HRH4 | Q9H3N8 | 4/20 | 0.36 |
| ▸ | IDH1 | O75874 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.32 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.31 |
| ▸ | HTR6 | P50406 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1551285 | 1.00 | HTR7 (0.38) | HTR7HRH4IDH1ALDH1A1HTT | |
| SCHEMBL1552281 | 1.00 | HTR7 (0.38) | HTR7HRH4IDH1ALDH1A1HTT | |
| SCHEMBL4004607 | 0.94 | HTR7 (0.41) | HTR7HRH4 | |
| SCHEMBL1551807 | 0.90 | HTR7 (0.42) | HTR7HRH4IDH1TSHR | |
| SCHEMBL1551811 | 0.90 | HTR7 (0.42) | HTR7HRH4IDH1TSHR | |
| SCHEMBL1552520 | 0.90 | HTR7 (0.42) | HTR7HRH4IDH1TSHR | |
| SCHEMBL6730951 | 0.82 | HTR7 (0.39) | HTR7IDH1ALDH1A1TSHRADRA1D | |
| SCHEMBL6726288 | 0.82 | HTR7 (0.39) | HTR7IDH1ALDH1A1TSHRADRA1D | |
| SCHEMBL6733937 | 0.82 | HTR7 (0.39) | HTR7IDH1ALDH1A1TSHRADRA1D | |
| SCHEMBL7978040 | 0.82 | HTR7 (0.46) | HTR7ALDH1A1HTTTSHRADRA1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2012588-B1 | AQUEOUS SUSPENSION CONCENTRATE | BAYER CROPSCIENCE AG (DE) | 2011-04-27 | — | — | EP | disclosed |
| EP-1958509-A1 | Herbicide combination | Bayer CropScience AG (DE) | 2008-08-20 | — | — | EP | disclosed |
| EP-1854355-A1 | Aqueous suspension concentrates | Bayer CropScience AG (DE) | 2007-11-14 | — | — | EP | disclosed |
| EP-1790227-A1 | Aqueous suspension-concentrates of 2,4-diamino-s-triazine herbicides | Bayer CropScience AG (DE) | 2007-05-30 | — | — | EP | disclosed |
| US-20010011063-A1 | Substituted 2,4-diamino-1,3,5-triazines, processes for their preparation and their use as herbicides and plant growth regulators | AVENTIS CROPSCIENCE GMBH (DE) | 2001-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010011063-A1 | Substituted 2,4-diamino-1,3,5-triazines, processes for their preparation and their use as herbicides and plant growth regulators | DDT, DAZAP1, SAT1 | HTR7 2152/4885HRH4 583/4885IDH1 382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.